via www.medgadget.com
To help address the global obesity epidemic, scientists are developing a new class of compounds called “micelle sequestrant polymers,” or MSPs, that could prevent fat particles from getting absorbed in the body and thus potentially reduce weight gain. They report on their novel agents, which they tested on mice, in the ACS journal Biomacromolecules.
Research has shown that worldwide, obesity rates have been climbing for years. Treatments for overweight and obesity include diet and exercise, surgery and prescription medications. But currently available drugs can have serious side effects, including increased risk of cardiovascular disease and depression. So Cory Berkland and colleagues set out to find new kinds of pharmaceuticals to fight weight gain.
Targeting the body’s process of absorbing fat, the researchers designed a class of polymers that capture fat particles called micelles in the intestines so they can’t be digested. Instead, they pass through the gut and are excreted. In tests, mice who took these MSPs had nine to 10 times the amount of triglycerides — the main dietary fat — in their feces than the control animals. Additionally, because the MSPs pass through the body unabsorbed, the researchers say they could provide a safe approach for long-term treatment.
The Latest on: Antiobesity Drug
via Google News
The Latest on: Antiobesity Drug
- Focus On - Obesityon May 27, 2022 at 10:18 am
Danish diabetes care giant Novo Nordisk’s success in diabetes and obesity drug sales could be impacted by supply chain issues, for the production of its obesity drug Wegovy (semaglutide), unless it ...
- Focus On - Saxenda, Drug Trialon May 27, 2022 at 6:46 am
Danish diabetes care giant Novo Nordisk last month released impressive data from its Phase IIIa STEP1 trial for semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in a bid to strengthen ...
- Essendon players reported injected with banned anti-obesity drug as well as controversial Thymosinon May 25, 2022 at 5:00 pm
The dossier shows some players were prescribed weekly injections of the banned anti-obesity drug AOD-9604 for the duration of the 2012 season. There are variants of Thymosin - some permitted for ...
- Anti-Obesity Drugs Market SWOT Analysis, Size, Share, Growth & Forecast 2030on May 24, 2022 at 7:57 am
Anti-Obesity Drugs Market business research report assesses the current as well as upcoming performance of the market, and also brand-new trends in the market. It provides product overview and ...
- Big Success for Anti-obesity Drugon May 24, 2022 at 7:50 am
When I saw this headline on an article in The Week magazine, I was impressed. Diet and exercise, when combined with existing obesity drugs, typically result in only a 10% weight loss; this new drug ...
- Essendon players allegedly admit to taking banned anti-obesity drug AOD-9604 last yearon May 20, 2022 at 5:00 pm
It has been reported "half a dozen" Bombers took the drug as part of the supplements program at Essendon last year, the subject of a joint Australian Sports Anti-Doping Authority-AFL investigation.
- Global Gastrointestinal Drugs Market Report 2022: Focus on Antacids, Antiulcerants, Antiobesity, Antiemetics and Antinauseants, & Antidiarrhoeals - Foon May 17, 2022 at 7:30 am
The "Gastrointestinal Drugs Global Market Report 2022, By Type, Drug Type, Distribution Channel, Route Of Administration, Drug Classification, Mode Of Purchase" report has been added to ...
- FDA approves new kind of diabetes drug with anti-obesity potentialon May 14, 2022 at 5:00 pm
It is also recommended the drug be used to control blood sugar alongside a diet and exercise program. Interestingly, these GLP-1 therapies have been recently investigated as strong anti-obesity ...
- Anti-Obesity Drugs Market SIZE 2028 (COVID-19 Impact Analysis Included) Opportunities, Regional Overview, Top Leaders, Revenue and Forecast to 2028on May 9, 2022 at 6:10 am
The proposed Anti-Obesity Drugs Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you ...
- Anti-Obesity Prescription Drugs Market Analysis, Growth Forecast Analysis by Manufacturers, Regions, Type and Application to 2028on May 4, 2022 at 6:13 pm
“Anti-Obesity Prescription Drugs Market” Report provides detail analysis on major industry drivers, restraints, and their effect on market growth during the estimate period. This report mainly ...
via Bing News
